Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Siemens healthcare diagnostics has confirmed that samples containing fluorescein may show interference with the advia centaur systems tsh3 ultra vitamin d and the advia centau brahms procalcitonin assays. samples containing fluorescein can produce falsely depressed values when tested with advia centaur tsh3 ultra assay. samples containing fluorescein can produce falsely depressed values when tested with the advia centaur brahms procalcitonin assay. samples containing fluorescein can produce falsely elevated values when tested with the advia centaur vitamin d assay.